Pivotal and Long-term Efficacy and Safety of ZEPOSIA in Relapsing Multiple Sclerosis: An Expert Video Series
Disease State
Introduction to ZEPOSIA
and Study Designs
Clinical Efficacy with
ZEPOSIA
BVL and SDMT Data
Safety and Tolerability
Dosing and Initiation
Summary and Important
Safety Information
This video is intended only for healthcare professionals in the US and is intended to be viewed as it was originally produced by Bristol Myers Squibb (BMS). The information provided is for educational purposes only. The contents of this video are intended to be viewed in their entirety.
This promotional video is being sponsored by BMS. The speaker is not an employee of BMS, but is being paid to present on its behalf.
The content of this video is consistent with the FDA-approved full Prescribing Information for any referenced BMS products.